News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dainippon Sumitomo Pharma Co., Ltd. Sumitomo Seeks SFDA Approval for Cancer Drug


9/4/2012 10:25:58 AM

by Richard Daverman, PhD

September 5, 2012 -- Dainippon Sumitomo Pharma Co. of Osaka, Japan submitted an imported drug registration application to the SFDA in China for amrubicin HCI, an antibiotic, as a treatment for small cell cancer. The drug has been approved for use in Japan since 2002, where it is called Calsed. Dainippon Sumitomo has completed a Phase III trial of the drug among China patients. More details....


Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES